SLC43A1 and ovarian cancer: Notably, the effect on oxaliplatin sensitivity upon LAT3 perturbation in 1A9 cells was minimal compared to the more dramatic effect in CRC cells, indicating the likelihood of other resistance mechanisms in the 1A9 highly selected oxaliplatin-resistant ovarian cancer cells.